Estrogen and progesterone receptor assays, by the EIA method (Abbott) , of low-speed supernates of breast-cancer homogenates
Hähnel, R.; Avenell, M.H.; Hähnel, E.
Clinical Chemistry 35(11): 2226-2227
1989
ISSN/ISBN: 0009-9147 PMID: 2684449 Document Number: 343838
Estrogen receptor (ER) and progesterone receptor (PR) assays were performed by solid-phase enzyme immunoassays (Abbott) on low-speed (2600 x g) and high-speed (100,000 x g) supernates of breast-cancer homogenates. The results were similar, indicating that ultracentrifugation is not essential for ER and PR assays with the Abbott kit.
Document emailed within 1 workday
Related Documents
Shen, X.Q. 1992: Comparative study of single-point method and multipoint method in the measurement of estrogen receptor and progesterone receptor in breast cancer Zhonghua Zhong Liu Za Zhi 14(2): 112-115Horwitz, K.B.; McGuire, W.L. 1978: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor Journal of Biological Chemistry 253(7): 2223-2228
Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2010: Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy Zhonghua Zhong Liu Za Zhi 32(7): 520-525
Avci, N.; Deligonul, A.; Tolunay, S.; Cubukcu, E.; Fatih Olmez, O.; Ulas, A.; Hartavi, M.; Kurt, E.; Evrensel, T. 2015: Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 20(1): 45-49
McGuire, W.L.; De La Garza, M.; Chamness, G.C. 1977: Evaluation of estrogen receptor assays in human breast cancer tissue Cancer Research 37(3): 637-639
Hendler, F.J.; Yuan, D. 1985: Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer Cancer Research 45(1): 421-429
Ferguson, A.T.; Lapidus, R.G.; Baylin, S.B.; Davidson, N.E. 1995: Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression Cancer Research 55(11): 2279-2283
Giuliani, S.; Leonardi, E.; Aldovini, D.; Bernardi, D.; Pellegrini, M.; Soli, F.; Ferro, A.; Dalla Palma, P.; Decarli, N.; Barbareschi, M. 2012: Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy Pathologica 104(3): 93-97
Bonomi, P.; Gale, M.; Von Roenn, J.; Anderson, K.; Johnson, P.; Wolter, J.; Economou, S. 1988: Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen Seminars in Oncology 15(2 Suppl 1: 26-33
Saez, S.; Martin, P.M.; Chouvet, C.D. 1978: Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels Cancer Research 38(10): 3468-3473
Nizamutdinova, I.T.; Lee, G.W.; Son, K.H.; Jeon, S.J.; Kang, S.S.; Kim, Y.S.; Lee, J.H.; Seo, H.G.; Chang, K.C.; Kim, H.J. 2008: Tanshinone i effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells International Journal of Oncology 33(3): 485-491
Castles, C.G.; Fuqua, S.A.; Klotz, D.M.; Hill, S.M. 1993: Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line Cancer Research 53(24): 5934-5939
Berger, U.; Wilson, P.; Thethi, S.; McClelland, R.A.; Greene, G.L.; Coombes, R.C. 1989: Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors Cancer Research 49(18): 5176-5179
Segreti, E.M.; Novotny, D.B.; Soper, J.T.; Mutch, D.G.; Creasman, W.T.; McCarty, K.S. 1989: Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor Obstetrics and Gynecology 73(5 Pt 1): 780-785
Biswas, D.K.; Cruz, A.P.; Pardee, A.B. 2000: Detection of the level of estrogen receptor and functional variants in human breast cancers by novel assays Biotechniques 29(5): 1056-60 1062-4
Pearce, P.T.; Myles, K.M.; Funder, J.W. 1993: Oestrogen and progesterone receptor assays in breast tumours. The Prince Henry's Hospital experience, 1983-1990 Medical Journal of Australia 159(4): 227-231
Rodier, J.F.; Millon, R.; Janser, J.C.; Rodier, D.; Velten, M.; Pusel, J.; Eber, M.; Abecassis, J. 1993: Influence of mastectomy techniques on estrogen and progesterone receptor analysis in carcinoma of the breast Surgery Gynecology and Obstetrics 177(4): 352-356
Ellinidi, V.N.; Anikeeva, N.V.; Goncharova, O.A.; Krasnozhon, D.A. 2005: Comparative evaluation of proliferative activity of breast tumors of different estrogen-progesterone receptor status Voprosy Onkologii 51(2): 197-199
Paone, J.F.; Abeloff, M.D.; Ettinger, D.S.; Arnold, E.A.; Baker, R.R. 1981: The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast Surgery Gynecology and Obstetrics 152(1): 70-74
Brdar, B.; Graf, D.; Padovan, R.; Nola, P.; Rudan, N.; Petrinec, Z.; Sarcević, B.; Belicza, M. 1988: Estrogen and progesterone receptors as prognostic factors in breast cancer Tumori 74(1): 45-52